Yi Shi
Vorstandsvorsitzender bei LAV Asset Management (Hong Kong) Ltd.
Profil
Yi Shi is the founder of IC Holdings Group, Inc. (founded in 2001) and LAV Management Co., Ltd.
(founded in 2008), where he holds the title of Managing Director.
Currently, Dr. Shi holds director positions at Novast Holdings Ltd., Ansun Biopharma, Inc., Elpiscience Biopharma Ltd., SciNeuro Pharmaceuticals, Beida Pharmaceutical Co., Ltd., and LAV Asset Management (Hong Kong) Ltd.
Dr. Shi previously held director positions at Innovent Biologics, Inc., Terns Pharmaceuticals, Inc., and Transcenta Holding Ltd.
Dr. Shi earned an MBA and a doctorate from Duke University.
Aktive Positionen von Yi Shi
Unternehmen | Position | Beginn |
---|---|---|
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Gründer | 01.01.2008 |
Novast Holdings Ltd.
Novast Holdings Ltd. Pharmaceuticals: MajorHealth Technology Novast Holdings Ltd. manufactures pharmaceutical products. It focuses on design and development of difficult formulations containing challenging APIs for worldwide markets. The firm collaborates with pharmaceutical and biotechnology companies to develop and commercialize products for regulated markets. The company also provides product development services in novel technologies and drug delivery systems. Novast Holdings was founded by Guohua Zhang in 2005 and is headquartered in Nantong, China. | Direktor/Vorstandsmitglied | - |
Ansun Biopharma, Inc.
Ansun Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ansun Biopharma, Inc. manufactures pharmaceutical products. Its products include Fludase, a drug candidate for the prophylaxis and treatment of respiratory infections caused by various types of influenza virus, including the types of virus that may cause a potential influenza pandemic, as well as various types of parainfluenza virus. The company was founded by Nancy Chang on August 9, 2012 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | 14.05.2018 |
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Direktor/Vorstandsmitglied | - |
Beida Pharmaceutical Co., Ltd. | Direktor/Vorstandsmitglied | - |
Scineuro Pharmaceuticals
Scineuro Pharmaceuticals BiotechnologyHealth Technology SciNeuro Pharmaceuticals is a Chinese clinical-stage biotechnology company that focuses on developing therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's disease. SciNeuro Pharmaceuticals is based in Shanghai, China, and has corporate and R&D facilities located in both Shanghai and Beijing. SciNeuro has built a portfolio of pipeline programs that address three key disease-driving mechanisms of neurodegeneration. The company is committed to delivering medicines that can make a difference in the lives of patients around the world. The company is an innovation-driven, neuroscience-focused biopharmaceutical company that uses in-house discovery and development to create innovative therapeutics for neurodegenerative and other CNS diseases. The company was founded in 2020 by Min Li, who has been the CEO since then. | Direktor/Vorstandsmitglied | - |
LAV Asset Management (Hong Kong) Ltd.
LAV Asset Management (Hong Kong) Ltd. Investment ManagersFinance LAV Asset Management (Hong Kong) Ltd. is a Chinese company that provides investment advice. The private company is based in Hong Kong, Hong Kong. The CEO of the company is Yi Shi. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Yi Shi
Unternehmen | Position | Ende |
---|---|---|
TERNS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | - |
Ic Holdings Group, Inc.
Ic Holdings Group, Inc. Internet Software/ServicesTechnology Services IC Holdings Group, Inc.engages in the provision of an online platform, which delivers solutions for research and development organizations. The company was founded by Alpheus Bingham, Darren J. Carroll, Jeff Hensley, Jill A. Panetta, Yi Shi, and Amiel M. Kornel in 2001 and is headquartered in Waltham, MA. | Gründer | - |
░░░░░░░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Yi Shi
Duke University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
INNOVENT BIOLOGICS, INC. | Health Technology |
TRANSCENTA HOLDING LIMITED | Health Technology |
TERNS PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 8 |
---|---|
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Finance |
Ic Holdings Group, Inc.
Ic Holdings Group, Inc. Internet Software/ServicesTechnology Services IC Holdings Group, Inc.engages in the provision of an online platform, which delivers solutions for research and development organizations. The company was founded by Alpheus Bingham, Darren J. Carroll, Jeff Hensley, Jill A. Panetta, Yi Shi, and Amiel M. Kornel in 2001 and is headquartered in Waltham, MA. | Technology Services |
Novast Holdings Ltd.
Novast Holdings Ltd. Pharmaceuticals: MajorHealth Technology Novast Holdings Ltd. manufactures pharmaceutical products. It focuses on design and development of difficult formulations containing challenging APIs for worldwide markets. The firm collaborates with pharmaceutical and biotechnology companies to develop and commercialize products for regulated markets. The company also provides product development services in novel technologies and drug delivery systems. Novast Holdings was founded by Guohua Zhang in 2005 and is headquartered in Nantong, China. | Health Technology |
Ansun Biopharma, Inc.
Ansun Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ansun Biopharma, Inc. manufactures pharmaceutical products. Its products include Fludase, a drug candidate for the prophylaxis and treatment of respiratory infections caused by various types of influenza virus, including the types of virus that may cause a potential influenza pandemic, as well as various types of parainfluenza virus. The company was founded by Nancy Chang on August 9, 2012 and is headquartered in San Diego, CA. | Health Technology |
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Health Technology |
Beida Pharmaceutical Co., Ltd. | |
Scineuro Pharmaceuticals
Scineuro Pharmaceuticals BiotechnologyHealth Technology SciNeuro Pharmaceuticals is a Chinese clinical-stage biotechnology company that focuses on developing therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's disease. SciNeuro Pharmaceuticals is based in Shanghai, China, and has corporate and R&D facilities located in both Shanghai and Beijing. SciNeuro has built a portfolio of pipeline programs that address three key disease-driving mechanisms of neurodegeneration. The company is committed to delivering medicines that can make a difference in the lives of patients around the world. The company is an innovation-driven, neuroscience-focused biopharmaceutical company that uses in-house discovery and development to create innovative therapeutics for neurodegenerative and other CNS diseases. The company was founded in 2020 by Min Li, who has been the CEO since then. | Health Technology |
LAV Asset Management (Hong Kong) Ltd.
LAV Asset Management (Hong Kong) Ltd. Investment ManagersFinance LAV Asset Management (Hong Kong) Ltd. is a Chinese company that provides investment advice. The private company is based in Hong Kong, Hong Kong. The CEO of the company is Yi Shi. | Finance |